Dr. Baechler Minneapolis Heart Institute Foundation

Courtney Jordan Baechler, MD, MS

Medical Director of Health Equity and Health Promotion

Dr. Courtney Jordan Baechler serves as program director for the Minneapolis Heart Institute Foundation’s emerging science centers including women’s cardiovascular research, prevention and global outreach. She is a general cardiologist at Minneapolis Heart Institute® who is passionate about a healthy state of wellbeing — body, mind and spirit — and is a national leader in integrative medicine and wellness. Dr. Jordan Baechler previously served as the Assistant Commissioner for Health Improvement for the State of Minnesota and also helped grow and lead the Penny George Institute for Health and Healing at Allina Health. She has served on the national prevention committee for the American College of Cardiology and the MN Department of Health State and Prevention of Cardiovascular and Stroke Committee.

Back to Prevention Team Back to Women's Team

Image
Twitter Icon
Image
LinkedIn Icon
Dr. Baechler Minneapolis Heart Institute Foundation
Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.